- Immunosuppressants
- Preservation Solutions
- Tissue Products
The global organ and tissue transplantation market is expected to grow at a CAGR of 7.7% during the forecast period 2023 to 2029. Organ and tissue transplantation saves many lives and restores the essential functions of the body. The organ transplantation is the medical procedure in which the organ is removed from one body and is placed in the recipient's body. The organs which can be transplanted include kidneys, heart, intestine, thymus, liver, lings and pancreas. The tissues include skin, cornea, heart valve, tendons and bones. The organ failure generally occurs owing to several conditions such as poising, serious trauma, drug abuse, and so on. The organ transplantation is the final stage of the treatment in organ failure. The organ and tissue transplantation market is also being boosted by the launch of technologically improved products and an increase in the number of tissue banks. However, several limitations, such as a scarcity of organ donors for transplantation, are projected to limit market expansion. The demand for organs for organ failure treatment is far greater than the supply, which can be linked to a variety of religious and traditional views, as well as a lack of awareness regarding organ donation. During the projection period, the immunosuppressive medications segment is expected to grow at the fastest rate. This is due to the widespread use of these medications to prevent tissue or organ rejection after transplantation. Organ replacements are becoming more popular as the prevalence of chronic diseases rises. As a result, demand for immunosuppressive medications is likely to surge during the predicted period.
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
Increase in the prevalence of chronic diseases and rising organ and tissue transplantation owing to organ damage or impairment is the key factor driving the growth of the market. The improving technology for organ and tissue transportation and transplantation is adding fuel for the growth of the market. The increasing investments in the research and development is providing opportunity for the growth of the market. However, the increasing incidence of the organ failures post-surgery is hampering the growth of the market. The limited number of donors is also and high cost involved in the treatment is expected to restrain the growth of the market. Lack of awareness regarding organ donation is likely to constrain the growth of the market.
2022 is the base year and 2029 is the forecast year.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
The global organ and tissue transplantation market is expected to grow at a CAGR of 7.7% during the forecast period 2023 to 2029.
1.Executive Summary |
2.Global Organ and Tissue Transplantation Market Introduction |
2.1.Global Organ and Tissue Transplantation Market - Taxonomy |
2.2.Global Organ and Tissue Transplantation Market - Definitions |
2.2.1.Product Type |
2.2.2.Application |
2.2.3.End User |
2.2.4.Region |
3.Global Organ and Tissue Transplantation Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global Organ and Tissue Transplantation Market Analysis, 2018-2022 and Forecast 2023-2029 |
4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global Organ and Tissue Transplantation Market By Product Type, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
5.1. Immunosuppressants |
5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Preservation Solutions |
5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Tissue Products |
5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
6.Global Organ and Tissue Transplantation Market By Application, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
6.1. Organ Transplantation |
6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Tissue Transplantation |
6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
7.Global Organ and Tissue Transplantation Market By End User, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
7.1. Hospitals |
7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Transplantation Centers |
7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Others |
7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
8.Global Organ and Tissue Transplantation Market By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
8.1. North America |
8.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Europe |
8.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Asia Pacific (APAC) |
8.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Middle East and Africa (MEA) |
8.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Latin America |
8.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
9.North America Organ and Tissue Transplantation Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
9.1. Product Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Immunosuppressants |
9.1.2.Preservation Solutions |
9.1.3.Tissue Products |
9.2. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.Organ Transplantation |
9.2.2.Tissue Transplantation |
9.3. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.Hospitals |
9.3.2.Transplantation Centers |
9.3.3.Others |
9.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.4.1.United States of America (USA) |
9.4.2.Canada |
10.Europe Organ and Tissue Transplantation Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
10.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Immunosuppressants |
10.1.2.Preservation Solutions |
10.1.3.Tissue Products |
10.2. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Organ Transplantation |
10.2.2.Tissue Transplantation |
10.3. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Hospitals |
10.3.2.Transplantation Centers |
10.3.3.Others |
10.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Germany |
10.4.2.France |
10.4.3.Italy |
10.4.4.United Kingdom (UK) |
10.4.5.Spain |
10.4.6.Rest of EU |
10.4.7. |
11.Asia Pacific (APAC) Organ and Tissue Transplantation Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Immunosuppressants |
11.1.2.Preservation Solutions |
11.1.3.Tissue Products |
11.2. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Organ Transplantation |
11.2.2.Tissue Transplantation |
11.3. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Hospitals |
11.3.2.Transplantation Centers |
11.3.3.Others |
11.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.China |
11.4.2.India |
11.4.3.Australia and New Zealand (ANZ) |
11.4.4.Japan |
11.4.5.Rest of APAC |
12.Middle East and Africa (MEA) Organ and Tissue Transplantation Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Immunosuppressants |
12.1.2.Preservation Solutions |
12.1.3.Tissue Products |
12.2. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Organ Transplantation |
12.2.2.Tissue Transplantation |
12.3. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Hospitals |
12.3.2.Transplantation Centers |
12.3.3.Others |
12.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.GCC Countries |
12.4.2.South Africa |
12.4.3.Rest of MEA |
13.Latin America Organ and Tissue Transplantation Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
13.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Immunosuppressants |
13.1.2.Preservation Solutions |
13.1.3.Tissue Products |
13.2. Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Organ Transplantation |
13.2.2.Tissue Transplantation |
13.3. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Hospitals |
13.3.2.Transplantation Centers |
13.3.3.Others |
13.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Brazil |
13.4.2.Mexico |
13.4.3.Rest of LA |
14. Competition Landscape |
14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
14.2.1.Hoffmann-La Roche Ltd. (Switzerland) |
14.2.2.Novartis International AG (Switzerland) |
14.2.3.OrganOX Limited (UK) |
14.2.4.Terumo Medical Corporation (US) |
14.2.5.Transonic (US) |
14.2.6.Bio Med Pvt. Ltd. (US) |
14.2.7.Transplant Biomedical (UK) |
14.2.8.GlaxoSmithKline Plc. (UK) |
14.2.9.Accord Healthcare GmbH (Spain) |
14.2.10.Sanofi (France) |
14.2.11.Pfizer, Inc. (US) |
15. Research Methodology |
16. Appendix and Abbreviations |